Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33164750.
- Also identified by DOI 10.7554/eLife.59980 and PMC identifier 7728435.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We determined differential gene expression in response to high glucose in lymphoblastoid cell lines derived from matched individuals with type 1 diabetes with and without retinopathy. Those genes exhibiting the largest difference in glucose response were assessed for association with diabetic retinopathy in a genome-wide association study meta-analysis. Expression quantitative trait loci (eQTLs) of the glucose response genes were tested for association with diabetic retinopathy. We detected an enrichment of the eQTLs from the glucose response genes among small association p-values and identified folliculin (<i>FLCN</i>) as a susceptibility gene for diabetic retinopathy. Expression of <i>FLCN</i> in response to glucose was greater in individuals with diabetic retinopathy. Independent cohorts of individuals with diabetes revealed an association of <i>FLCN</i> eQTLs with diabetic retinopathy. Mendelian randomization confirmed a direct positive effect of increased <i>FLCN</i> expression on retinopathy. Integrating genetic association with gene expression implicated <i>FLCN</i> as a disease gene for diabetic retinopathy.
Medical subject headings
- Diabetes Mellitus, Type 1
- Diabetic Retinopathy
- Gene Expression Profiling
- Glucose
- Lymphocytes
- Polymorphism, Single Nucleotide
- Proto-Oncogene Proteins
- Transcriptome
- Tumor Suppressor Proteins